Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HoT-PE home treatment trial with rivaroxaban for low-risk acute pulmonary embolism
NL-OMON45455Phase 4Active, not recruiting
- Sponsor
- University Medical Center Mainz
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rivaroxaban in pulmonary embolism (PE), sponsored by University Medical Center Mainz. Primary endpoint: Primary efficacy outcome. Started Jul 2017; status: active, not recruiting.
02
Drugs
rivaroxaban
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NL-OMON45455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45455.